CeriBell 13G/A: 1.57M Shares (4.2%) Disclosed
CeriBell, Inc. reports a Schedule 13G/A filing by The Global Value Investment Portfolio Management Pte Ltd and affiliated reporting persons.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CeriBell, Inc. reports a Schedule 13G/A filing by The Global Value Investment Portfolio Management Pte Ltd and affiliated reporting persons.
The filing states beneficial ownership of 1,572,146 shares of Common Stock, equal to 4.2% of the class based on 37,859,680 shares outstanding as of March 31, 2026. The shares are held by u.life fund and none are held by GVIP Ventures SPC-SP3. The filing attributes shared voting and shared dispositive power of 1,572,146 shares to the reporting persons through The Global Value Investment Portfolio Management Pte Ltd and notes Caroline Kwong as Managing Director. Signature dates appear as May 14, 2026.
Insights
Routine beneficial-ownership disclosure reflecting sub-5% passive stake.
The filing lists 1,572,146 shares and states that the amount represents 4.2% of the outstanding common shares as of March 31, 2026. It attributes voting and dispositive authority to the reporting entities through The Global Value Investment Portfolio Management Pte Ltd and names Caroline Kwong as Managing Director.
Because the position is below 5.0% and is reported on Schedule 13G/A, the filing is consistent with passive ownership disclosure practices; subsequent filings would show changes if the holders cross the 5.0% threshold.
Position size is a non-controlling minority stake; impact is limited absent further accumulation.
The reported stake of 1,572,146 shares equals 4.2% of a 37,859,680 share base (as of March 31, 2026), which is below common disclosure/filing triggers for control or mandatory offer thresholds in many jurisdictions.
Market-relevant items to watch in future filings include any increase above 5.0% or changes in voting/dispositive power; cash-flow treatment and trading intent are not stated in this excerpt.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does The Global Value Investment Portfolio Management Pte Ltd report in CeriBell (CBLL)?
What is the reporting date and signature date on the Schedule 13G/A for CBLL?
Is this Schedule 13G/A indicative of active control or a passive stake in CBLL?
AI-generated analysis. How Rhea-AI works. Not financial advice.